JP2016505804A5 - - Google Patents

Download PDF

Info

Publication number
JP2016505804A5
JP2016505804A5 JP2015538145A JP2015538145A JP2016505804A5 JP 2016505804 A5 JP2016505804 A5 JP 2016505804A5 JP 2015538145 A JP2015538145 A JP 2015538145A JP 2015538145 A JP2015538145 A JP 2015538145A JP 2016505804 A5 JP2016505804 A5 JP 2016505804A5
Authority
JP
Japan
Prior art keywords
subject
formulation
day
restriction
days
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015538145A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016505804A (ja
JP6325555B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/066236 external-priority patent/WO2014066426A1/en
Publication of JP2016505804A publication Critical patent/JP2016505804A/ja
Publication of JP2016505804A5 publication Critical patent/JP2016505804A5/ja
Application granted granted Critical
Publication of JP6325555B2 publication Critical patent/JP6325555B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015538145A 2012-10-22 2013-10-22 組織/器官再生、寿命、およびヘルススパンを増進する方法および製剤 Active JP6325555B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261716676P 2012-10-22 2012-10-22
US61/716,676 2012-10-22
US201261736308P 2012-12-12 2012-12-12
US61/736,308 2012-12-12
US201261746787P 2012-12-28 2012-12-28
US61/746,787 2012-12-28
PCT/US2013/066236 WO2014066426A1 (en) 2012-10-22 2013-10-22 Methods and formulations promoting tissue/organ regeneration, longevity and healthspan

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018076600A Division JP2018140989A (ja) 2012-10-22 2018-04-12 組織/器官再生、寿命、およびヘルススパンを増進する方法および製剤

Publications (3)

Publication Number Publication Date
JP2016505804A JP2016505804A (ja) 2016-02-25
JP2016505804A5 true JP2016505804A5 (enExample) 2016-12-01
JP6325555B2 JP6325555B2 (ja) 2018-05-16

Family

ID=50485540

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015538145A Active JP6325555B2 (ja) 2012-10-22 2013-10-22 組織/器官再生、寿命、およびヘルススパンを増進する方法および製剤
JP2018076600A Pending JP2018140989A (ja) 2012-10-22 2018-04-12 組織/器官再生、寿命、およびヘルススパンを増進する方法および製剤
JP2021000121A Pending JP2021061849A (ja) 2012-10-22 2021-01-04 組織/器官再生、寿命、およびヘルススパンを増進する方法および製剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2018076600A Pending JP2018140989A (ja) 2012-10-22 2018-04-12 組織/器官再生、寿命、およびヘルススパンを増進する方法および製剤
JP2021000121A Pending JP2021061849A (ja) 2012-10-22 2021-01-04 組織/器官再生、寿命、およびヘルススパンを増進する方法および製剤

Country Status (6)

Country Link
US (3) US10015980B2 (enExample)
EP (1) EP2909802B1 (enExample)
JP (3) JP6325555B2 (enExample)
CA (1) CA2888811C (enExample)
ES (1) ES2822178T3 (enExample)
WO (1) WO2014066426A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2822178T3 (es) 2012-10-22 2021-04-29 Univ Southern California Formulaciones dietéticas que promueven la regeneración de tejidos/órganos
US9237761B2 (en) * 2013-02-12 2016-01-19 University Of Southern California Methods and diets for lowering glucose and/or IGF-1 levels
AU2014284399B2 (en) 2013-07-01 2017-10-26 University Of Southern California Fasting condition as dietary treatment of diabetes
US10172839B2 (en) 2014-03-06 2019-01-08 University Of Southern California Use of short term starvation regimen in combination with kinase inhibitors to enhance traditional chemo-drug efficacy and feasibility and reverse side effects of kinases in normal cells and tissues
RU2687750C2 (ru) * 2014-04-02 2019-05-16 Юниверсити Оф Саутерн Калифорния Лечение аутоиммунной реакции и рассеянного склероза
BR112017023748A2 (pt) * 2015-05-06 2018-07-31 University Of Southern California métodos para tratar hipertensão; reduzir níveis de colesterol elevados e/ou níveis de ldl elevados; reduzir níveis de triglicerídeo elevados e/ou níveis de crp elevados; tratar um indivíduo com níveis de insulina ou glicose elevados; tratar obesidade abdominal; tratar um indivíduo com níveis de igf-1 elevados; tratar ou prevenir inflamação; aumentar regeneração; e reduzir fígado gorduroso
JP2019504073A (ja) * 2016-01-12 2019-02-14 ユニバーシティ オブ サザン カリフォルニア 多発性骨髄腫及び他のがんに対する食事療法としての長期断食模倣の使用
RU2018131403A (ru) 2016-02-15 2020-03-17 Юниверсити Оф Саутерн Калифорния Комбинации лекарственных средств и способы стимуляции эмбрионоподобной регенерации для лечения сахарного диабета и других заболеваний
AU2017261723B2 (en) 2016-05-11 2023-02-09 University Of Southern California Fasting mimicking diet (FMD) as an immunoregulatory treatment for gastrointestinal autoimmune/inflammatory diseases.
IT201700008499A1 (it) 2017-01-26 2018-07-26 Univ Degli Studi Genova Composizione dietetica per la prevenzione e/o il trattamento dell’iperplasia dell’endometrio
US11284640B2 (en) 2017-02-14 2022-03-29 University Of Southern California Fasting mimicking diet
JP7216711B2 (ja) * 2017-09-12 2023-02-01 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 長期的なカロリー制限を再現し、動物に健康上の利益を与えるための方法
AU2019236242A1 (en) * 2018-03-15 2020-10-01 University Of Southern California Fasting-mimicking diet (FMD) but not water-only fasting promotes reversal of inflammation and IBD pathology
DE212018000421U1 (de) 2018-07-18 2021-03-01 Andreas Michalsen Auswirkungen einer kurzzeitigen Diät, die Fasten imitiert, auf die Lebensqualität und die Verträglichkeit einer Chemotherapie bei Patientinnen mit Krebs
CA3119100C (en) 2018-11-09 2024-06-04 Valter D. Longo Nutrition bar for intermittent fasting-mimicking
JP2022530671A (ja) * 2019-04-30 2022-06-30 ユニバーシティ オブ サザン カリフォルニア アルツハイマー病(ad)の介入のための断食模倣食(fmd)
IT202000008740A1 (it) 2020-04-23 2021-10-23 L Nutra Inc Composizione dietetica per l’incremento della massa magra e della massa muscolare
IT202000016957A1 (it) 2020-07-13 2022-01-13 Univ Degli Studi Di Palermo Composizione dietetica per il trattamento della depressione
EP4190173B1 (en) * 2020-09-23 2024-07-17 Aminovita S.L. Metabolic cancer therapy
TW202227113A (zh) 2020-12-01 2022-07-16 南加州州立大學 模擬禁食飲食提升急性淋巴母細胞白血病模型中的無癌存活
TW202236983A (zh) 2020-12-03 2022-10-01 南加州州立大學 提升骨骼肌再生及強度的模擬禁食生酮飲食(fmd)
US20220175007A1 (en) * 2020-12-09 2022-06-09 University Of Southern California Fasting mimicking ketogenic diet to improve immune function and vaccine response and minimize risk in adults and elderly
WO2024044036A1 (en) * 2022-08-23 2024-02-29 University Of Southern California Dietary compositions to extend longevity while maximizing strength and function
EP4714272A1 (en) 2024-09-18 2026-03-25 L-Nutra Inc. Diet composition for the prevention and/or the treatment of hyposmia and hypogeusia

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1356252A (en) 1970-03-25 1974-06-12 Briggs J H Pryor J S Fryers G Dietetic foodstuffs
WO2002047702A1 (en) 2000-12-15 2002-06-20 Naturalendo Tech Co., Ltd. Compositions for inducing secretion of insulin-like growth factor-1
US20020106308A1 (en) 2001-02-02 2002-08-08 Zweifel Ronald A. Microdrop dispensing apparatus
US8821915B2 (en) * 2002-08-09 2014-09-02 Veroscience, Llc Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
US20060063827A1 (en) * 2004-09-23 2006-03-23 Yu Ruey J Systemic administration of therapeutic amino acids and N-acetylamino acids
US20070116802A1 (en) 2005-11-23 2007-05-24 Carl Germano High quality caloric composition
US20080038367A1 (en) * 2006-08-11 2008-02-14 Sal Saloum Nutritional supplement compositions and methods of preparing
EP2104501B1 (en) * 2006-12-13 2014-03-12 Merck Sharp & Dohme Corp. Methods of cancer treatment with igf1r inhibitors
ES2891733T3 (es) 2007-03-28 2022-01-31 Univ Southern California Inducción de la resistencia diferencial al estrés y usos de la misma
US8865646B2 (en) 2007-03-28 2014-10-21 University Of South California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
CA2706656A1 (en) * 2007-11-26 2009-06-04 Nestec S.A. Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition
CA2748119A1 (en) * 2008-12-23 2010-07-01 Salk Institute For Biological Studies Method of treating neurodegenerative disease
CA2779282C (en) * 2009-10-22 2017-12-05 University Of Southern California Methods and nutritional formulations to increase the efficacy and reduce the side effects of cancer treatment
US20130045215A1 (en) 2010-04-28 2013-02-21 University Of Southern California Growth hormone receptor deficiency causes a major reduction in pro-aging signaling, cancer and diabetes in humans
WO2012109353A2 (en) 2011-02-08 2012-08-16 University Of Southern California Growth hormone receptor deficiency causes a major reduction in pro-aging signaling, cancer and diabetes in humans
WO2012113415A1 (en) * 2011-02-24 2012-08-30 N.V. Nutricia Ketogenic diet composition for the treatment of chemo therapy and/or radiation therapy patients
ES2822178T3 (es) 2012-10-22 2021-04-29 Univ Southern California Formulaciones dietéticas que promueven la regeneración de tejidos/órganos
US9237761B2 (en) * 2013-02-12 2016-01-19 University Of Southern California Methods and diets for lowering glucose and/or IGF-1 levels

Similar Documents

Publication Publication Date Title
Paddon-Jones et al. Dietary protein recommendations and the prevention of sarcopenia
Wu et al. Dietary supplementation with L-arginine or N-carbamylglutamate enhances intestinal growth and heat shock protein-70 expression in weanling pigs fed a corn-and soybean meal-based diet
Anastacio et al. Nutrition therapy: Integral part of liver transplant care
JP2018012722A5 (enExample)
JP2016509994A5 (enExample)
AU2012299126B2 (en) Compositions and methods for use in promoting lean body mass
RU2015134780A (ru) Способы и рационы для защиты от химической интоксикации и связанных с возрастом заболеваний
US20150017260A1 (en) Compositions of nutrition supplementation for nutritional deficiencies and method of use thereof
JP2024149504A (ja) 断続的断食模倣のための栄養バー
HUE032597T2 (en) Nutritional composition for stimulating muscle protein synthesis
JP2009536016A (ja) アミノ酸を含む食品組成物
WO2007145239A1 (ja) アミノ酸組成物を含有する疲労防止剤
CN101842094A (zh) 含有氨基酸组合物的抗疲劳剂
WO2015194447A1 (ja) 糖代謝改善剤
JP2022538265A (ja) 骨格筋における状態又は障害を予防又は治療するための、トリゴネリン及び高タンパク質を使用する組成物及び方法
WO2019008104A1 (en) FORTIFYING HUMAN MILK
CN111315239A (zh) 针对肌肉质量和/或肌肉量使用橄榄苦苷或姜黄素的组合物和方法
CA2905817A1 (en) Reducing the risk of autoimmune disease
Hodkovicova et al. The use of functional amino acids in different categories of pigs–A review
Naclerio et al. Intake of animal protein blend plus carbohydrate improves body composition with no impact on performance in endurance athletes
WO2007057748A2 (en) Use of colostrum for the prophylaxis of influenza syndromes
CN105451732B (zh) 脂质代谢促进剂
Serafini et al. Nutritional approach to sarcopenia
Seo Strategies for long-term weight loss and maintenance
Mishra et al. Effect of recombinant bovine somatotropin (Boostin-250) on blood metabolites and milk yield of lactating buffaloes